SUMMARY – Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was…
project
-
-
AgrochemicalsGlobal MarketPharma Science & Research
Tiziana Announces Submission of Amendment to Investigational New Drug Application to Advance Oral Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, in Patients with Crohn’s Disease
by adminby adminSummary – – Tiziana is Developing the First Oral Form of Foralumab in a Convenient Capsule to be Evaluated in Phase 1b…
-
AgrochemicalsGlobal MarketPharma Science & Research
Liver Cancer Insight Report: Current Therapies, Drug Pipeline and Outlook
by adminby adminSummary : Liver cancer, also known as hepatic cancer and primary hepatic cancer, is a relatively rare form of cancer that has…
-
AgrochemicalsGlobal MarketPharma Science & Research
mdgroup Newly Appointed Medical Director Dr Arthur Lazarus Addresses Remote Patient Healthcare Selection at SCOPE 2022
by adminby adminSynopsis : mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director. Dr Lazarus…
-
AgrochemicalsGlobal Market
ION receives continued listing standard notice from the NYSE
by adminby adminSynopsis : ION Geophysical Corporation (NYSE: IO) today announced that it received notice on January 31, 2022 from the New York Stock…
-
RegulatorySanofiU.S FDA
FDA approves Enjaymo™ (sutimlimab-jome), First Treatment for use in Patients with Cold Agglutinin Disease
by adminby adminSummary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment…
-
Agrochemicals
Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
by adminby adminSynopsis : Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative…
-
Synopsis : Sanofi has been a global healthcare leader that has brought forth treatments for rare diseases and established standard-of-care therapeutics for…
-
CompaniesPfizer
Valneva and Pfizer report further positive Phase 2 data for Lyme disease vaccine candidate
by adminby adminSynopsis : Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive…
-
AgrochemicalsPharma Science & Research
Three exposures to spike protein allow people to develop broad antibody immunity – also against Omicron
by adminby adminSummary : Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is…